Literature DB >> 26646632

Emerging roles of ATRX in cancer.

L Ashley Watson1,2,3, Hannah Goldberg1,2,3, Nathalie G Bérubé1,2,3.   

Abstract

ATRX was identified over 20 years ago as the gene responsible for a rare developmental disorder characterized by α-thalassemia and intellectual disability. Similarities to the sucrose nonfermentable SNF2 type chromatin remodelers initially suggested a role in transcriptional regulation. However, over the last years, our knowledge of the epigenetic activities of ATRX has expanded steadily. Recent exciting discoveries have propelled ATRX into the limelight of chromatin and telomere biology, development and cancer research. This review summarizes recent breakthroughs in understanding ATRX function in heterochromatin structure, genome stability and its frequent dysregulation in a variety of cancers.

Entities:  

Keywords:  ATRX; DAXX; DNA replication; G quadruplexes; alternative lengthening of telomeres; cancer; chromatin; histone H3.3; p53; telomeres

Mesh:

Substances:

Year:  2015        PMID: 26646632     DOI: 10.2217/epi.15.82

Source DB:  PubMed          Journal:  Epigenomics        ISSN: 1750-192X            Impact factor:   4.778


  32 in total

Review 1.  Mutant ATRX: uncovering a new therapeutic target for glioma.

Authors:  Santiago Haase; María Belén Garcia-Fabiani; Stephen Carney; David Altshuler; Felipe J Núñez; Flor M Méndez; Fernando Núñez; Pedro R Lowenstein; Maria G Castro
Journal:  Expert Opin Ther Targets       Date:  2018-06-20       Impact factor: 6.902

2.  Molecular evaluation of a sporadic paraganglioma with concurrent IDH1 and ATRX mutations.

Authors:  Jing Zhang; Jingjing Jiang; Yu Luo; Xiaomu Li; Zhiqiang Lu; Yujun Liu; Jie Huang; Yingyong Hou; Ying Pang; Mitchell Yee Fong Sun; Tracy S Wang; Douglas B Evans; Karel Pacak; Zhengping Zhuang; Xin Gao
Journal:  Endocrine       Date:  2018-05-30       Impact factor: 3.633

Review 3.  Advances in the molecular genetics of gliomas - implications for classification and therapy.

Authors:  Guido Reifenberger; Hans-Georg Wirsching; Christiane B Knobbe-Thomsen; Michael Weller
Journal:  Nat Rev Clin Oncol       Date:  2016-12-29       Impact factor: 66.675

4.  A promising Prognostic risk model for advanced renal cell carcinoma (RCC) with immune-related genes.

Authors:  Peng Cao; Ji-Yue Wu; Jian-Dong Zhang; Ze-Jia Sun; Xiang Zheng; Bao-Zhong Yu; Hao-Yuan Cao; Fei-Long Zhang; Zi-Hao Gao; Wei Wang
Journal:  BMC Cancer       Date:  2022-06-23       Impact factor: 4.638

Review 5.  Deciphering the Role of the Barr Body in Malignancy: An insight into head and neck cancer.

Authors:  Deepti Sharma; George Koshy; Shruti Gupta; Bhushan Sharma; Sonal Grover
Journal:  Sultan Qaboos Univ Med J       Date:  2018-01-10

6.  Functional cross talk between the Fanconi anemia and ATRX/DAXX histone chaperone pathways promotes replication fork recovery.

Authors:  Maya Raghunandan; Jung Eun Yeo; Ryan Walter; Kai Saito; Adam J Harvey; Stacie Ittershagen; Eun-A Lee; Jihyeon Yang; Maureen E Hoatlin; Anja K Bielinsky; Eric A Hendrickson; Orlando Schärer; Alexandra Sobeck
Journal:  Hum Mol Genet       Date:  2020-05-08       Impact factor: 6.150

7.  ATRX Alteration Contributes to Tumor Growth and Immune Escape in Pleomorphic Sarcomas.

Authors:  Lucie Darmusey; Gaëlle Pérot; Noémie Thébault; Sophie Le Guellec; Nelly Desplat; Laëtitia Gaston; Lucile Delespaul; Tom Lesluyes; Elodie Darbo; Anne Gomez-Brouchet; Elodie Richard; Jessica Baud; Laura Leroy; Jean-Michel Coindre; Jean-Yves Blay; Frédéric Chibon
Journal:  Cancers (Basel)       Date:  2021-04-29       Impact factor: 6.639

8.  ATRX binds to atypical chromatin domains at the 3' exons of zinc finger genes to preserve H3K9me3 enrichment.

Authors:  David Valle-García; Zulekha A Qadeer; Domhnall S McHugh; Flávia G Ghiraldini; Asif H Chowdhury; Dan Hasson; Michael A Dyer; Félix Recillas-Targa; Emily Bernstein
Journal:  Epigenetics       Date:  2016-03-30       Impact factor: 4.528

9.  Cancer Cells with Alternative Lengthening of Telomeres Do Not Display a General Hypersensitivity to ATR Inhibition.

Authors:  Katharina I Deeg; Inn Chung; Caroline Bauer; Karsten Rippe
Journal:  Front Oncol       Date:  2016-08-23       Impact factor: 6.244

10.  Prognostic Significance of Altered ATRX/DAXX Gene in Pancreatic Neuroendocrine Tumors: A Meta-Analysis.

Authors:  Fei Wang; Xiaowu Xu; Zeng Ye; Yi Qin; Xianjun Yu; Shunrong Ji
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-18       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.